Login / Signup

Checkpoint Inhibition for Kidney Transplant Recipients With Advanced Cutaneous Carcinomas: An Emerging Standard for Select Patients.

Shlomo A KoyfmanJessica L Geiger
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • dna damage
  • prognostic factors
  • high grade
  • oxidative stress
  • cell proliferation
  • patient reported outcomes